Robert W. Baird upgraded shares of Express Scripts (NASDAQ:ESRX) from a neutral rating to an outperform rating in a research note published on Friday morning, MarketBeat reports. The firm currently has $81.00 price objective on the stock, up from their prior price objective of $72.00.

Several other equities research analysts also recently weighed in on ESRX. SunTrust Banks set a $82.00 price target on Express Scripts and gave the stock a buy rating in a report on Thursday, December 14th. BidaskClub upgraded Express Scripts from a hold rating to a buy rating in a report on Thursday, December 14th. Maxim Group increased their price target on Express Scripts from $78.00 to $87.00 and gave the stock a buy rating in a report on Thursday, December 14th. Sanford C. Bernstein upgraded Express Scripts from an underperform rating to a market perform rating in a report on Wednesday, December 6th. Finally, ValuEngine upgraded Express Scripts from a hold rating to a buy rating in a report on Monday, October 2nd. Five analysts have rated the stock with a sell rating, ten have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of Hold and an average target price of $74.40.

Shares of Express Scripts (NASDAQ ESRX) opened at $73.38 on Friday. Express Scripts has a 52-week low of $55.80 and a 52-week high of $73.46. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. The stock has a market capitalization of $40,523.99, a P/E ratio of 10.46, a price-to-earnings-growth ratio of 1.06 and a beta of 0.88.

Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, hitting the consensus estimate of $1.90. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The firm had revenue of $24.68 billion for the quarter, compared to the consensus estimate of $25.68 billion. During the same period in the prior year, the business posted $1.74 earnings per share. The company’s revenue for the quarter was down 2.9% on a year-over-year basis. equities research analysts predict that Express Scripts will post 7.02 EPS for the current year.

In other news, CEO Timothy C. Wentworth acquired 8,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 31st. The shares were bought at an average price of $61.13 per share, with a total value of $489,040.00. Following the completion of the purchase, the chief executive officer now directly owns 98,628 shares in the company, valued at $6,029,129.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Phyllis S. Anderson sold 643 shares of the stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total value of $40,103.91. The disclosure for this sale can be found here. 0.68% of the stock is owned by corporate insiders.

Large investors have recently made changes to their positions in the stock. Trust Co boosted its position in Express Scripts by 5.9% during the 1st quarter. Trust Co now owns 3,572 shares of the company’s stock valued at $235,000 after acquiring an additional 200 shares in the last quarter. Capital Asset Advisory Services LLC bought a new stake in Express Scripts during the 2nd quarter valued at $312,000. Factory Mutual Insurance Co. boosted its position in Express Scripts by 2.4% during the 2nd quarter. Factory Mutual Insurance Co. now owns 766,488 shares of the company’s stock valued at $48,933,000 after acquiring an additional 18,000 shares in the last quarter. Atria Investments LLC boosted its position in Express Scripts by 53.1% during the 2nd quarter. Atria Investments LLC now owns 9,431 shares of the company’s stock valued at $602,000 after acquiring an additional 3,270 shares in the last quarter. Finally, Private Trust Co. NA boosted its position in Express Scripts by 13.8% during the 2nd quarter. Private Trust Co. NA now owns 11,351 shares of the company’s stock valued at $724,000 after acquiring an additional 1,378 shares in the last quarter. 88.44% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Robert W. Baird Upgrades Express Scripts (ESRX) to Outperform” was published by Watch List News and is owned by of Watch List News. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.watchlistnews.com/robert-w-baird-upgrades-express-scripts-esrx-to-outperform/1772096.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.